Active Leptospermum Honey Heals Clinically Complex or Chronic Wounds

Share this article:

WASHINGTON, DC—Oncology nurses should consider using active leptospermum honey (ALH) in treating patients with cancer with clinically complex or chronic wounds. That's the conclusion of research presented at the Oncology Nursing Society (ONS) 38th Annual Congress.

“All wounds exhibited signs of decreased inflammatory response, increase in healthy tissue, or wound closure,” reported Patrice Dillow, RN, WOCN, MSN, APRN, of Cancer Treatment Centers of America,Zion, IL. “Promotion of normal wound healing progression and pain control are key issues for oncology nurses.”

The study assessed outcomes for oncology patients with clinically complex wounds by evaluating the effectiveness of ALH dressings in a variety of formats. After failing to heal with traditional wound care, six patients (5 female and 1 male) ages 39 to 64 years with varying wound/integumentary issues—including surgical sites, radiation dermatitis, and tumor presence—were treated using a variety of ALH dressings. In addition to a diagnosis of cancer, the majority had 2 to 3 comorbidities.

Four of the six patients were treated with a new hydrogel colloidal sheet (MH-HCS) impregnated with ALH; the other two were treated with ALH gel and absorbent dressings or negative pressure therapy for excessive exudates.

“All patients initially reporting pain on evaluation reported a decrease in their pain levels,” Dillow noted. “Having ALH available in different formats makes it a valuable and versatile tool as part of the total wound care treatment plan.”

The combined mechanism of actions of ALH include creating an osmotic potential; decreasing edema; stimulating cytokines to promote normal healing; and bringing pH level into balance. The use of ALH, which is supported by peer-reviewed publications and research presentations, is increasing among the oncologic patient population.

“Use of these advanced dressings in this patient population improved quality of care and warrants further research. Oncology nurses should consider this evidence based alternative when dealing with clinically complex or chronic wounds,” the researchers concluded.

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in ONS Annual Congress 2013

Preventing Catheter-Associated UTIs Goal of Comprehensive Education Program

An initiative to prevent catheter-associated urinary tract infections provided the nursing staff with the best evidence for the care of the oncology patient with an indwelling urinary catheter, found research presented at the ONS 38th Annual Congress.

High Dose Cytarabine Neurological Assessment Guide Streamlines Symptom Documentation

A neurological assessment guide has helped nurses to assess and document the use of high-dose cytarabine, according to research presented at the ONS 38th Annual Congress.

Oral Electrolyte Replacement as Effective as IV Replacement in Adult Oncology Population

Oral electrolyte replacement is as effective as intravenous replacement in the adult oncology population, research presented at the ONS 38th Annual Congress has shown.